Released Mar 8, 2018, before the open
10-K filed Mar 8, 2018, 67 days after period end · 0001144204-18-013474
Q4 2017 · 10-K
Revenue$3.32M$3.32M no prior Q4 2016 on file+24.6% vs Q3 2017
Net Income-$3.01M-$3.01M N/M vs Q4 2016N/M vs Q3 2017
EPS Diluted-$160.00-$160.00 N/M vs Q4 2016N/M vs Q3 2017
Operating Incomederived-$12,279,740N/M
Operating Cash Flowderived-$9,770,144N/M
Free Cash Flowderived-$10,132,029N/M
Margins · derived
Operating margin-370.4%
Net margin-90.7%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $3.32M | — | — | — |
| Net Income | -$3.01M | -$11.55M | -$7.75M | -$6.23M |
| EPS Diluted | -$160.00 | -$0.67 | -$0.45 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR